Molecular Imaging

Latest News

What a New PSMA PET/CT Study Reveals About Local PCa Treatment and High-Risk Recurrence
What a New PSMA PET/CT Study Reveals About Local PCa Treatment and High-Risk Recurrence

May 16th 2025

For patients at high-risk for biochemical recurrence of prostate cancer, PSMA PET/CT findings revealed that 77 percent had one or more prostate lesions after undergoing local radiation therapy or radical prostatectomy, according to a recent study.

Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging

May 7th 2025

FDA Clears Dual-Head SPECT/CT System with Deep Learning Image Reconstruction
FDA Clears Dual-Head SPECT/CT System with Deep Learning Image Reconstruction

May 6th 2025

PSMA PET/CT Study Shows Mixed Results with Single Metastasis-Directed Radiotherapy for Oligometastatic PCa
PSMA PET/CT Study Shows Mixed Results with Single Metastasis-Directed Radiotherapy for Oligometastatic PCa

May 5th 2025

Self-Interpretation of Imaging by Non-Radiologists Accounts for 43.5 Percent of Medicare Imaging Claims
Self-Interpretation of Imaging by Non-Radiologists Accounts for 43.5 Percent of Medicare Imaging Claims

April 3rd 2025

© 2025 MJH Life Sciences

All rights reserved.